jueves, 15 de octubre de 2026

How Far Away Are Oncologists From Diagnosing Ovarian Cancer Earlier? Zoe Cunniffe

https://www.medscape.com/viewarticle/how-far-away-are-oncologists-diagnosing-ovarian-cancer-2026a10012p4?src= Two biotechnology companies are in the process of developing liquid biopsy tests that could detect ovarian cancer at early stages. While these tools by Mercy BioAnalytics and DELFI Diagnostics are not yet FDA-approved, recent trials showed that they are much more sensitive than current screening methods for identifying stages I and II ovarian cancer.

No hay comentarios:

Publicar un comentario